NETRIS BIOMEDICAL

OUR PURPOSE

The purpose of the Company is to develop universal platform approaches to effectively treat multiple pathologies associated with or accompanied by the formation of neutrophil extracellular traps (NETs). Together with their protective role in microbial infections, NETs are involved in multiple pathological processes and represent key events in a variety of pathologies including cancer, autoimmunity, COVID, and cardiovascular disease. The platform is based on targeted co-delivery to the sites of pathological NETs accumulation of NET-destroying or NET-preventing actives together with medicines treating the main disease (such as anticancer or thrombolytic drugs).